1. Knudtson MD, Klein BE, Klein R, Cruickshanks KJ, Lee KE. Age-related eye disease, quality of life, and functional activity. Arch Ophthalmol 2005;123:807-814.

2. Jung CS, Bruce B, Newman NJ, Biousse V. Visual function in anterior ischemic optic neuropathy: Effect of Vision Restoration Therapy—A pilot study. J Neurol Sci 2008;268:145-149.

3. Brown MM, Brown GC, Sharma S, Landy J, Bakal J. Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration. Arch Ophthalmol 2002;120:481-484.

4. Optic Neuritis Study Group. Visual function 15 years after optic neuritis: A final follow-up report from the Optic Neuritis Treatment Trial. Ophthalmology 2008;115:1079-1082.e5.

5. Jiang Z, Qian H, Wei S. Vision-related quality of life in patients with atypical optic neuritis. Front Pain Res 2022;3:871269.

6. Su Y, Bai G, Tian H, Zhang S, Liu Y, Zhang G, et al. Visionrelated quality of life and association between retinal parameters in patients with non-arteritic anterior ischemic optic neuropathy. Int J Gen Med 2022;15:5173-5179.

7. Mathew RS, Delbaere K, Lord SR, Beaumont P, Vaegan, Madigan MC. Depressive symptoms and quality of life in people with age-related macular degeneration. Ophthalmic Physiol Opt 2011;31:375-380.

8. Mackenzie PJ, Chang TS, Scott IU, Linder M, Hay D, Feuer WJ, et al. Assessment of vision-related function in patients with age-related macular degeneration. Ophthalmology 2002;109:720-729.

9. Sahel JA, Bandello F, Augustin A, Maurel F, Negrini C, Berdeaux GH; MICMAC Study Group. Health-related quality of life and utility in patients with age-related macular degeneration. Arch Ophthalmol 2007;125:945-951.

10. Matamoros E, Maurel F, Léon N, Solomiac A, Bardoulat I, Joubert M, et al. Quality of life in patients suffering from active exudative age-related macular degeneration: The EQUADE study. Ophthalmologica 2015;234:151-159.

11. Kappel PJ, Monnet D, Yu F, Brezin AP, Levinson RD, Holland GN. Contrast sensitivity among patients with birdshot chorioretinopathy. Am J Ophthalmol 2009;147:351-356.e2.

12. Levinson RD, Monnet D, Yu F, Holland GN, Gutierrez P, Brezin AP. Longitudinal cohort study of patients with birdshot chorioretinopathy. V. Quality of life at baseline. Am J Ophthalmol 2009;147:346-350.e2.

13. Kaisari E, Loeliger J, Thorne JE, Monnet D, Imikirene L, Kecili S, et al. Quality of life in patients with birdshot chorioretinitis aged 80 and older. Ocul Immunol Inflamm 2025;33:280-286.

14. Monnet D, Brézin AP, Holland GN, Yu F, Mahr A, Gordon LK, et al.; Baseline Clinical Characteristics. Longitudinal cohort study of patients with birdshot chorioretinopathy. I. Baseline clinical characteristics. Am J Ophthalmol 2006;141:135-142.

15. Breukink MB, Dingemans AJ, den Hollander AI, Keunen JE, MacLaren RE, Fauser S, et al. Chronic central serous chorioretinopathy: Long-term follow-up and vision-related quality of life. Clin Ophthalmol 2016;11:39-46.

16. Karska-Basta I, Pociej-Marciak W, Chrz¹szcz M, ¯uber- £askawiec K, Sanak M, Romanowska-Dixon B. Quality of life of patients with central serous chorioretinopathy - A major cause of vision threat among middle-aged individuals. Arch Med Sci 2020;17:724-730.

17. Hufnagel HJ, Lahmann C, Agostini H, Lange C, Pauleikhoff LJ; Retina.net CCS study group. Psychometric assessment of patients with central serous chorioretinopathy and correlation with disease stage and progression: A casecontrol study. BMC Ophthalmol 2024;24:92.

18. ªahin A, Bez Y, Kaya MC, Türkcü FM, ªahin M, Yüksel H. Psychological distress and poor quality of life in patients with central serous chorioretinopathy. Semin Ophthalmol 2014;29:73-76.

19. Kumar M, van Dijk EH, Raman R, Mehta P, Boon CJ, Goud A, et al. Stress and vision-related quality of life in acute and chronic central serous chorioretinopathy. BMC Ophthalmol 2020;20:90.

20. Pennesi ME, Birch DG, Jayasundera KT, Parker M, Tan O, Gurses-Ozden R, et al.; For The Xlrs-Study Group. Prospective evaluation of patients with X-linked retinoschisis during 18 months. Invest Ophthalmol Vis Sci 2018;59:5941-5956.

21. Turriff A, Nolen R, D’Amanda C, Biesecker B, Cukras C, Sieving PA. “There are hills and valleys”: Experiences of parenting a son with X-linked retinoschisis. Am J Ophthalmol 2020;212:98-104.

22. Hariprasad SM, Mieler WF, Grassi M, Green JL, Jager RD, Miller L. Vision-related quality of life in patients with diabetic macular oedema. Br J Ophthalmol 2008;92:89-92.

23. Gonder JR, Walker VM, Barbeau M, Zaour N, Zachau BH, Hartje JR, et al. Costs and quality of life in diabetic macular edema: Canadian Burden of Diabetic Macular Edema Observational Study (C-REALITY). J Ophthalmol 2014;2014:939315.

24. Turkoglu EB, Celýk E, Aksoy N, Bursalý O, Ucak T, Alagoz G. Changes in vision related quality of life in patients with diabetic macular edema: Ranibizumab or laser treatment? J Diabetes Complications 2015;29:540-543.

25. Fenwick EK, Man RE, Gan AT, Kumari N, Wong C, Aravindhan A, et al. Beyond vision loss: The independent impact of diabetic retinopathy on vision-related quality of life in a Chinese Singaporean population. Br J Ophthalmol 2019;103:1314-1319.

26. Fenwick EK, Xie J, Ratcliffe J, Pesudovs K, Finger RP, Wong TY, et al. The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes. Invest Ophthalmol Vis Sci 2012;53:677-684.

27. Matza LS, Rousculp MD, Malley K, Boye KS, Oglesby A. The longitudinal link between visual acuity and health-related quality of life in patients with diabetic retinopathy. Health Qual Life Outcomes 2008;6:95.

28. Pan CW, Wang S, Wang P, Xu CL, Song E. Diabetic retinopathy and health-related quality of life among Chinese with known type 2 diabetes mellitus. Qual Life Res 2018;27:2087-2093.

29. Vijayan M, Jose R, Jose S, Abraham S, Joy J. Study on quality of life assessment in diabetic retinopathy among patients with type 2 diabetic patients. Asian J Pharm Clin Res 2017;10:116-119.

30. Venkataraman K, Wee HL, Leow MK, Tai ES, Lee J, Lim SC, et al. Associations between complications and healthrelated quality of life in individuals with diabetes. Clin Endocrinol 2013;78:865-873.

31. Gebremariam GT, Biratu S, Alemayehu M, Welie AG, Beyene K, Sander B, et al. Health-related quality of life of patients with type 2 diabetes mellitus at a tertiary care hospital in Ethiopia. PLoS One 2022;17:e0264199.

32. Alcubierre N, Rubinat E, Traveset A, Martinez-Alonso M, Hernandez M, Jurjo C, et al. A prospective cross-sectional study on quality of life and treatment satisfaction in type 2 diabetic patients with retinopathy without other major late diabetic complications. Health Qual Life Outcomes 2014;12:131.

33. Khashayar P, Shirzad N, Zarbini A, Esteghamati A, Hemmatabadi M, Sharafi E. Diabetes-related distress and its association with the complications of diabetes in Iran. J Diabetes Metab Disord 2022;21:1569-1575.

34. Huang ES, Brown SE, Ewigman BG, Foley EC, Meltzer DO. Patient perceptions of quality of life with diabetesrelated complications and treatments. Diabetes Care 2007;30:2478-2483.

35. Lui JN, Lau ES, Yang A, Wu H, Fu A, Lau V, et al. Temporal associations of diabetes-related complications with healthrelated quality of life decrements in Chinese patients with type 2 diabetes: A prospective study among 19 322 adults- Joint Asia Diabetes Evaluation ( JADE) register (2007- 2018). J Diabetes 2024;16:e13503.

36. Porta M, Grosso A, Veglio F. Hypertensive retinopathy: There’s more than meets the eye. J Hypertens 2005;23:683-696.

37. Kabedi NN, Mwanza JC, Lepira FB, Kayembe TK, Kayembe DL. Hypertensive retinopathy and its association with cardiovascular, renal and cerebrovascular morbidity in Congolese patients. Cardiovasc J S Afr 2014;25:228-232.

38. Del Brutto OH, Mera R, Recalde BY, Rumbea DA, Costa AF, Viteri E. Hypertensive retinopathy and all-cause mortality in older adults of Amerindian ancestry. A populationbased longitudinal prospective study. High Blood Press Cardiovasc Prev 2021;28:613-618.

39. Shrestha T, Shrestha R, Kaiti R. Study of characteristic retinal findings among hypertensive population attending a tertiary care hospital in Nepal. Kathmandu Univ Med J. 2022;20:3-6.

40. Quinn GE, Dobson V, Saigal S, Phelps DL, Hardy RJ, Tung B, et al.; CRYO-ROP Cooperative Group. Healthrelated quality of life at age 10 years in very low-birthweight children with and without threshold retinopathy of prematurity. Arch Ophthalmol 2004;122:1659-1666.

41. Kesarwani P, Narang S, Chawla D, Jain S, Chandel M, Sood S. Vision-related quality of life in children with treated retinopathy of prematurity. Indian J Ophthalmol 2019;67:932-935.

42. Sriram S, Jensen E, Msall M, Yi J, Zhabotynsky V, Joseph R, et al. Retinopathy of prematurity and neurodevelopmental outcome and quality of life at 10 years of age. Research Square [Preprint]. 2024:rs.3.rs-4324566. Available from: 10.21203/rs.3.rs-4324566/v1

43. Fieß A, Greven K, Mildenberger E, Urschitz MS, Elflein HM, Zepp F, et al. Visual acuity, amblyopia, and visionrelated quality of life in preterm adults with and without ROP: Results from the Gutenberg prematurity eye study. Eye 2023;37:1794-1801.

44. Potic J, Bergin C, Giacuzzo C, Konstantinidis L, Daruich A, Wolfensberger TJ. Application of modified NEI VFQ- 25 after retinal detachment to vision-related quality of life. Retina 2021;41:653-660.

45. Okamoto F, Okamoto Y, Hiraoka T, Oshika T. Visionrelated quality of life and visual function after retinal detachment surgery. Am J Ophthalmol 2008;146:85-90. e1.

46. Mozaffarieh M, Sacu S, Benesch T, Wedrich A. Mental health measures of anxiety and depression in patients with retinal detachment. Clin Pract Epidemiol Ment Health 2007;3:10.

47. Zou H, Zhang X, Xu X, Liu H. Quality of life in subjects with rhegmatogenous retinal detachment. Ophthalmic Epidemiol 2008;15:212-217.

48. Garcia GA, Khoshnevis M, Yee KM, Nguyen-Cuu J, Nguyen JH, Sebag J. Degradation of contrast sensitivity function following posterior vitreous detachment. Am J Ophthalmol 2016;172:7-12.

49. Fukuda S, Okamoto F, Yuasa M, Kunikata T, Okamoto Y, Hiraoka T, et al. Vision-related quality of life and visual function in patients undergoing vitrectomy, gas tamponade and cataract surgery for macular hole. Br J Ophthalmol 2009;93:1595-1599.

50. Singh A, Kendal A, Trivedi D, Cazabon S. Patient expectation and satisfaction after macular hole surgery. Optom Vis Sci 2011;88:312-316.

51. Sebag J. Floaters and the quality of life. Am J Ophthalmol 2011;152:3-4. e1.

52. Wagle AM, Lim W-Y, Yap T-P, Neelam K, Eong K-GA. Utility values associated with vitreous floaters. Am J Ophthalmol 2011;152:60-65. e1.

53. Yannuzzi NA, Callaway NF, Sridhar J, Smiddy WE. Internal limiting membrane peeling during pars plana vitrectomy for rhegmatogenous retinal detachment: Cost analysis, review of the literature, and meta-analysis. Retina 2018;38:2081-2087.

54. Humphries A, Bowman L, Nguyen T, So J, Duff M, Grover S, et al. Quality of life analysis in patients with retinitis pigmentosa. Ophthalmic Res 2024;67:348-357.

55. Miura G, Baba T, Tatsumi T, Yokouchi H, Yamamoto S. Effects of cataract surgery on vision-related quality of life in patients with retinitis pigmentosa and the predictive factors of quality of life improvement. BioMed Res Int 2021;2021:3846867.

56. Altinbay D, Taskin I. Evaluation of vision-related quality of life in retinitis pigmentosa patients with low vision. Jpn J Ophthalmol 2021;65:777-785.

57. Anil K, Garip G. Coping strategies, vision-related quality of life, and emotional health in managing retinitis pigmentosa: A survey study. BMC Ophthalmol 2018;18:21.

58. Levinson JD, Joseph E, Ward LA, Nocera JR, Pardue MT, Bruce BB, et al. Physical activity and quality of life in retinitis pigmentosa. J Ophthalmol 2017;2017:6950642.

59. Chaumet-Riffaud AE, Chaumet-Riffaud P, Cariou A, Devisme C, Audo I, Sahel JA, et al. Impact of retinitis pigmentosa on quality of life, mental health, and employment among young adults. Am J Ophthalmol 2017;177:169-174.

60. Sugawara T, Hagiwara A, Hiramatsu A, Ogata K, Mitamura Y, Yamamoto S. Relationship between peripheral visual field loss and vision-related quality of life in patients with retinitis pigmentosa. Eye 2010;24:535-539.

61. Burstedt MS, Mönestam E. Self-reported quality of life in patients with retinitis pigmentosa and maculopathy of Bothnia type. Clin Ophthalmol 2010;4:147-154.

62. Seo JH, Yu HG, Lee BJ. Assessment of functional vision score and vision-specific quality of life in individuals with retinitis pigmentosa. Korean J Ophthalmol 2009;23:164-168.

63. Watanabe K, Aouadj C, Hiratsuka Y, Yamamoto S, Murakami A. Quality of life and economic impacts of retinitis pigmentosa on Japanese patients: A non-interventional cross-sectional study. Adv Ther 2023;40:2375-2393.

64. Prem Senthil M, Khadka J, Pesudovs K. Seeing through their eyes: Lived experiences of people with retinitis pigmentosa. Eye 2017;31:741-748.

65. Gomes ML, Mansur-Pantuzzo ER, Lagos AA, Corrêa H, Duarte D, Frasson M. Evaluating vision-specific quality of life and functional vision in a Brazilian population with Stargardt disease. Eur J Ophthalmol 2022;33:11206721221121023.

66. Gomes ML, Corrêa H, Duarte D, Rückl S, Brancaglion MY, Frasson M. Depression and quality of life in individuals with Stargardt’s disease. J Bras Psiquiatr 2020;69:44-47.

67. Murro V, Sodi A, Giacomelli G, Mucciolo DP, Pennino M, Virgili G, et al. Reading ability and quality of life in Stargardt disease. Eur J Ophthalmol 2017;27:740-745.

68. Moschos MM, Nitoda E, Lavaris A. Estimation of depression prevalence in patients with Stargardt disease using PHQ-9 and Zung scores. Eur J Ophthalmol 2016;26:268-272.

69. Anastasakis A, Thobani A, Fishman GA, McAnany JJ. Educational levels in patients with stargardt disease. Am J Ophthalmol 2010;150:737-740. e2.

70. Karuntu JS, Nguyen XT, Talib M, van Schooneveld MJ, Wijnholds J, van Genderen MM, et al. Quality of life in patients with CRB1-associated retinal dystrophies: A longitudinal study. Acta Ophthalmol 2024;102:469-477.

71. Shojaei S, Sabbaghi H, Mehrabi Y, Daftarian N, Etemad K, Ahmadieh H. Vision-related quality of life in patients with inherited retinal dystrophies. J Curr Ophthalmol 2022;34:80-86.

72. Yioti G, Stefaniotou M, Ziavrou I, Kotsis K, Hyphantis T. Illness perceptions, psychiatric manifestations, and quality of life in patients with inherited retinal dystrophies. Semin Ophthalmol 2017;32:428-437.

73. Prem Senthil M, Khadka J, De Roach J, Lamey T, McLaren T, Campbell I, et al. Development and psychometric assessment of novel item banks for hereditary retinal diseases. Optom Vis Sci 2019;96:27-34.

74. Rabenstein A, Catarino CB, Rampeltshammer V, Schindler D, Gallenmüller C, Priglinger C, et al. Smoking and alcohol, health-related quality of life and psychiatric comorbidities in Leber’s Hereditary Optic Neuropathy mutation carriers: A prospective cohort study. Orphanet J Rare Dis 2021;16:127.

75. Kirkman MA, Korsten A, Leonhardt M, Dimitriadis K, De Coo IF, Klopstock T, et al. Quality of life in patients with Leber hereditary optic neuropathy. Invest Ophthalmol Vis Sci 2009;50:3112-3115.

76. McGuinness MB, Ayton LN, Schofield D, Britten-Jones AC, Chen FK, Grigg JR, et al. EQ-5D-5L health utility scores in Australian adults with inherited retinal diseases: A crosssectional survey. Acta Ophthalmol 2024;102:e736-45.

77. Bijveld MM, van Genderen MM, Hoeben FP, Katzin AA, van Nispen RM, Riemslag FC, et al. Assessment of night vision problems in patients with congenital stationary night blindness. PLoS One 2013;8:e62927.

78. Cammack J, Whight J, Cross V, Rider AT, Webster AR, Stockman A. Psychophysical measures of visual function and everyday perceptual experience in a case of congenital stationary night blindness. Clin Ophthalmol 2016;10:1593-1606.

79. Organization WH. Xerophthalmia and night blindness for the assessment of clinical vitamin A deficiency in individuals and populations. World Health Organization; 2014.

80. Wolfram C, Lorenz K, Breitscheidel L, Verboven Y, Pfeiffer N. Health- and vision-related quality of life in patients with ocular hypertension or primary open-angle glaucoma. Ophthalmologica 2013;229:227-234.

81. Riva I, Legramandi L, Rulli E, Konstas AG, Katsanos A, Oddone F, et al.; Italian Study Group on QoL in Glaucoma. Vision-related quality of life and symptom perception change over time in newly-diagnosed primary open angle glaucoma patients. Sci Rep 2019;9:6735.

82. Majernikova, L’udmila, Hudakova A, Obrocnikova A, Gress Halasz B, Kascakova M. Quality of life of patients with glaucoma in Slovakia. Int J Environ Res Public Health 2021;18.

83. Zhang Q, Zhou W, Song D, Xie Y, Lin H, Liang Y, et al. Vision-related quality of life in patients with glaucoma: the role of illness perceptions. Health Qual Life Outcomes 2022;20:78.

84. Knight LS, Ridge B, Staffieri SE, Craig JE, Prem Senthil M, Souzeau E. Quality of life in children with glaucoma: A qualitative interview study in Australia. BMJ Open 2022;12:e062754.

85. Sen S, Mishra A, Das M, Iyer V, Sethi M. Assessment of quality of life in glaucoma patients in a tertiary care center in Eastern India. Indian J Ophthalmol 2023;71:2767-2772.

86. Peasgood T, Brennan A, Mansell P, Elliott J, Basarir H, Kruger J. The impact of diabetes-related complications on preference-based measures of health-related quality of life in adults with type I diabetes. Med Decis Making 2016;36:1020-1033.

87. Parik PC, Patel VJ. Health-related quality of life of patients with type 2 diabetes mellitus at a tertiary care hospital in India using EQ-5D-5L. Indian J Endocrinol Metab 2019;23:407-411.

88. Brody BL, Roch-Levecq AC, Gamst AC, Maclean K, Kaplan RM, Brown SI. Self-management of age-related macular degeneration and quality of life: A randomized controlled trial. Arch Ophthalmol 2002;120:1477-1483.

89. Berdeaux GH, Nordmann JP, Colin E, Arnould B. Visionrelated quality of life in patients suffering from age-related macular degeneration. Am J Ophthalmol 2005;139:271-279.

90. Šiaudvytytė L, Mitkutė D, Balčiūnienė J. Quality of life in patients with agerelated macular degeneration. Medicina 2012;48:15.

91. Vu KV, Mitchell P, Detaram HD, Burlutsky G, Liew G, Gopinath B. Risk factors for poorer quality of life in patients with neovascular age-related macular degeneration: A longitudinal clinic-based study. Eye 2023;37:2736-2743.